Delivery Order SPE2DB20D3104-SPE2DB24FV9E4

Award Date 9/4/24
Potential Completion Date 9/5/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $14,191.98, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, with a completion date of March 24, 2025. This appears to be a Firm Fixed Price Delivery Order contract, without any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award from the Defense Logistics Agency (DLA) was issued to the AmerisourceBergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The $77,101.72 delivery order contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of September 13, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,136.72, is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. The contract has an ultimate completion date of November 22, 2023 and is a firm fixed-price delivery order. There is no set-aside designation for this award....
This federal contract award, valued at $4,741.17, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. This is a firm fixed-price delivery order contract with a completion date of February 25, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This federal contract award, valued at $26,757.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and an Ultimate Completion Date of May 8, 2024. This award is not associated with a set-aside designation. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor in the United States. The contract, valued at $7,330.51, is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of July 31, 2024. The contract is not set aside for any specific business type. This contract award is likely part of a larger Indefinite...
This $9,465.38 firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty pharmaceutical product, with a completion date of September 18, 2024. This award is part of AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS. The contract, valued at $2,367.18, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. The contract is for firm fixed-price delivery of the pharmaceutical product, with no set-aside...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,299.57, is a Firm Fixed Price Delivery Order for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS medical products. The contract has an ultimate completion date of March 25, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor on this award, which is part of a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,271.53, is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. The contract has a completion date of November 15, 2024 and is a Firm Fixed Price Delivery Order. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp is the prime contractor, and there...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB24FV9E4
    Delivery Order

This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor in the United States. The contract, valued at $11,082.96, is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 5, 2024. This award is not designated as a set-aside contract. AmerisourceBergen, through its Corporate Office division, has been awarded multiple federal contracts and Indefinite Delivery Contracts (IDCs) by various government agencies, including the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, to supply a wide range of pharmaceutical and medical products to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 12/4/24, 9:36 AM